St. John's Wort for Depression: From Neurotransmitters to Membrane Plasticity
Verena M Merk1, Georg Boonen1, Veronika Butterweck1
1Medical Department, Max Zeller Söhne AG, 8590 Romanshorn, Switzerland.
International Journal of Molecular Sciences
|December 30, 2025
Summary
St. John's wort, an herbal antidepressant, may work by stabilizing cell membranes. Lipidomic studies reveal its extract normalizes membrane fluidity and receptor function, offering new insights into depression treatment.
Area of Science:
- Pharmacology
- Neuroscience
- Lipidomics
Background:
- Depression is a complex disorder with various proposed causes, including neurochemical imbalances and stress.
- St. John's wort (Hypericum perforatum L.) is a widely used herbal remedy for mild-to-moderate depression.
- Its antidepressant effects are traditionally attributed to neurotransmitter modulation, but novel mechanisms are emerging.
Purpose of the Study:
- To review the mechanisms of St. John's wort as an antidepressant.
- To focus on the impact of St. John's wort extracts on cell membrane properties.
- To highlight the role of lipidomics in understanding its antidepressant activity.
Main Methods:
- Review of existing literature on St. John's wort mechanisms.
- Analysis of lipidomic studies investigating Hypericum perforatum extracts (e.g., Ze 117).
- Examination of effects on membrane fluidity, lipid composition, and receptor function in cellular and animal models.
Main Results:
- St. John's wort extracts, particularly Ze 117, counteract stress-induced increases in membrane fluidity.
- These extracts modulate lipid composition and cholesterol metabolism, stabilizing cell membranes.
- Effects include normalization of receptor mobility (e.g., β1-adrenoceptors) and signal transduction.
- Modulation of glycerophospholipid metabolism was observed in cellular and animal models.
Conclusions:
- St. John's wort exhibits membrane-stabilizing properties that complement its known neurochemical actions.
- Lipidomic analysis provides a promising approach to elucidate the full spectrum of its antidepressant activity.
- Understanding these membrane-level effects could lead to personalized depression therapies.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
761
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
761
G-protein Coupled Receptors
131.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.3K
Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K


